Your browser doesn't support javascript.
loading
Neonatal hypothyroidism despite maternal tri-iodothyronine toxicosis: a management problem?
V Shenoy, Vasant; Nisbet, Janelle; G Petersen, Scott; David Mcintyre, H.
Affiliation
  • V Shenoy V; Obstetric Medicine, Mater Health Services, University of Queensland, Brisbane, Queensland, Australia.
  • Nisbet J; Maternal and Fetal Medicine, Mater Health Services and Mater Medical Research Institute, Brisbane, Queensland, Australia.
  • G Petersen S; Obstetric Medicine, Mater Health Services and Mater Medical Research Institute, University of Queensland, Brisbane, Queensland, Australia.
  • David Mcintyre H; Obstetric Medicine, Mater Health Services, University of Queensland, Brisbane, Queensland, Australia.
Obstet Med ; 5(4): 178-180, 2012 Dec.
Article in En | MEDLINE | ID: mdl-30705701
ABSTRACT
A primigravida was referred with hyperthyroidism in early pregnancy from longstanding Graves' disease treated with propylthiouracil. She had selective elevation of free tri-iodothyronine (fT3) levels, low normal free tetra-iodothyronine (fT4) and suppressed thyroid-stimulating hormone (TSH). Given her symptoms of thyrotoxicosis and elevated TSH receptor antibodies, therapy was tailored towards maintaining clinical and biochemical euthyroidism. However the fetus developed a goitre secondary to hypothyroidism. This case highlights the dilemmas in managing maternal T3 toxicosis while aiming for a high normal fT4 to prevent fetal hypothyroidism including the role of fetal ultrasound monitoring and amniocentesis.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Obstet Med Year: 2012 Document type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Obstet Med Year: 2012 Document type: Article Affiliation country: Australia